230 likes | 315 Views
Explore the chemical variances of EPA and DHA lipids and their influence on various drug classes in dyslipidemia and hypertriglyceridemia. Learn about the efficacy of EPA-rich Icosapent Ethyl, anti-inflammatory effects, and the mechanisms through which EPA may reduce cardiovascular disease incidence.
E N D
Lipid Effects of Drug Classes in Dyslipidemia and Hypertriglyceridemia
Icosapent Ethyl (Pure EPA)Median Placebo-Adjusted Change From Baseline for Efficacy End Points
Effects of Omega-3 on Incident Heart FailureGISSI-Heart Failure Study
Omega-3 Ethyl Esters and Lipid Levels in Patients With Triglycerides > 500 mg/dL
Reduction of Cardiovascular Events With EPA – Intervention Trial